AlveoGene will be attending JP Morgan Week in San Francisco and hosting a number of meetings with clients and clients and partners regarding the next stages of pipeline development for AVG-001 (Alpha-1 antitrypsin deficiency) and AVG-002 (Surfactant Protein B deficiency).

If you would like to meet with us to explore collaboration please email us on [email protected]